Arthneeti

Medplus Health Services Q2 FY27 Share Price & Earnings Call Analysis

₹579.90-3.03% today
Market cap
₹6,964 Cr
P/E
33.08
ROE
11.64%
PEG
0.50
Price to sales
0.96
Debt to equity
0.72
52W high / low
₹954 / ₹580
Sales growth (5Y)
17.56%
EBITDA margin
8.44%
Net profit margin
3.14%
Promoter holding
40.19%
Sales (last year)
₹7,229 Cr

India's Leading Pharmacy Company[1][2] MedPlus is the 2nd largest pharmacy retailer in India, with 4,930 stores across 13 states and 1 union territory, serving 750 cities as of Q2 FY26. These stores are strategically distributed to maintain a high presence in metro, tier-one, and tier-two cities.

Guidance scorecard · Q2 FY27 call

What Medplus Health Services Ltd's management guided
and where it ranks in Retailing

Revenue20–40%MarginsFlatCapexNone plannedFundraisingWhat management saidOrder bookWhat management said

RevenueQ1 FY27 call

20–40%
  • MedPlus aims for a Same Store Sales Growth (SSSG) target of around 9%-10% for the full year FY27, though the Q1 reported SSSG was 15%.
  • Company expects volume growth driven by new store openings and better performance of existing stores.
  • Franchise store additions remain on track with guidance of 800 net store openings for FY27.
  • Revenue growth is expected to remain strong, with quarterly growth of 22% observed recently.
  • Management emphasizes stabilizing and increasing private label share, contributing to margin improvement and revenue recovery.
  • The company remains focused on contiguous state expansion rather than rapid pan-India expansion for the core pharmacy business.

2 more points from Medplus Health Services Ltd's call on revenue

Create a free account to keep reading this call

Full Q1 FY27 analysis

MarginsQ1 FY27 call

Flat

See what Medplus Health Services Ltd said on margins — free account, 30 seconds.

Full Q1 FY27 analysis

CapexQ1 FY27 call

None planned
  • The company had approved capex plans including INR40 crores for a food park and oil extraction unit and another for a wellness services facility.
  • These capex proposals have now been put on hold as of July 2026 after further deliberation and market feedback.
  • Management emphasized that capex on the core business—warehousing and stores—has not stopped and will continue.
  • Core business investments will continue.
  • Wellness and concierge medicine-related expansion plans, initially considered, are unlikely to proceed for the moment.

2 more points from Medplus Health Services Ltd's call on capex

Create a free account to keep reading this call

Full Q1 FY27 analysis

FundraisingQ1 FY27 call

See what Medplus Health Services Ltd said on fundraising — free account, 30 seconds.

Full Q1 FY27 analysis

Order bookQ1 FY27 call

Ask what Medplus Health Services Ltd said on the order book →

Full Q1 FY27 analysis
Full Retailing ranking

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Retailing
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Entero Healthcare Solutions LtdGood growth
    3
See all potential multibaggersWhere does Medplus Health Services Ltd rank?

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Retailing companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Flat₹6,264 Cr38.2
240%+Flat₹6,053 Cr53.9
3Entero Healthcare Solutions Ltd20–40%Up 0–2%₹6,899 Cr53.5
420–40%Up 0–2%₹790 Cr19.0
520–40%Flat₹3.14L Cr725.0
620–40%Flat₹1.12L Cr170.8

Sign up free to see every company in the sector ranking and track Medplus Health Services Ltd.

Pro shows every company guiding 40%+ revenue growth →Full Retailing ranking

Financials of Medplus Health Services Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Shareholder Pattern

Medplus Health Services Ltd

Shareholding breakup across reporting periods.

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters +40.45%40.39%40.39%40.39%40.39%40.33%40.32%40.29%40.29%40.22%40.19%40.20%
FIIs +12.96%14.94%14.85%14.72%15.23%15.61%16.43%16.53%16.83%15.53%14.38%12.58%
DIIs +25.19%22.47%22.17%27.98%25.66%26.19%26.03%26.51%26.58%27.82%29.95%31.89%
Public +21.31%22.10%22.51%16.85%18.68%17.82%17.18%16.60%16.27%16.41%15.45%15.31%
Others +0.10%0.10%0.08%0.07%0.05%0.05%0.05%0.05%0.04%0.04%0.04%0.04%
No. of Shareholders66,04874,97676,93487,32883,91283,43981,74278,33779,15777,27876,00577,714

Financials of Medplus Health Services Ltd

Quarterly Results

Quarter-by-quarter operating performance

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales +1,4091,4411,4901,4891,5761,5611,5101,5431,6791,8061,8641,8802,037
Expenses +1,3241,3501,3851,3951,4521,4291,3731,4121,5301,6481,6951,7461,867
Operating Profit859210694124133136131149159169133170
OPM %6%6%7%6%8%8%9%8%9%9%9%7%8%
Other Income +1010109121316151718212021
Interest24242525252627272931333337
Depreciation55575960636264666973767884
Profit before tax16203218485761536973804270
Tax %12%31%-5%19%19%19%16%20%19%21%20%21%20%
Net Profit +15143414394651425658643356
EPS in Rs1.221.152.791.203.243.834.293.544.634.825.332.764.67

Financials of Medplus Health Services Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales +1,3681,7332,0112,1312,2732,8713,0693,7794,5585,6256,1366,8927,587
Expenses +1,3361,6961,9402,0732,1532,7372,8523,5074,2925,2705,6486,2846,956
Operating Profit32377158120134217273266355488608631
OPM %2.4%2.1%3.5%2.7%5%4.7%7%7%6%6%8%9%8%
Other Income +4878111721314640487179
Interest14171928504755668396103120134
Depreciation9101112597588119182224250283310
Profit before tax141948262329951184773183275266
Tax %46%52%40%-65%48%94%34%20%-6%11%18%20%
Net Profit +79294212263955066150220211
EPS in Rs37.3045.25144.15169.4047.688.72277.658.034.175.4812.5618.3017.58
Dividend Payout %0%0%0%0%0%0%0%0%0%0%0%0%

Financials of Medplus Health Services Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital0.170.170.170.190.190.190.45242424242424
Reserves1411371483032915287301,3941,4671,5541,7171,9512,044
Borrowings +1702232041624294775908159001,0101,1201,4241,549
Other Liabilities +126149183179239344245361406417500533581
Total Liabilities4385095356449591,3491,5662,5942,7973,0053,3603,9334,198
Fixed Assets +677781833774195177991,1381,2421,2961,5951,718
CWIP3321156202511163238
Investments00000000000082
Other Assets +3684294535605809241,0431,7751,6331,7522,0472,3062,360
Total Assets4385095356449591,3491,5662,5942,7973,0053,3603,9334,198

Financials of Medplus Health Services Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +-19-173432147-7317090144540496
Cash from Investing Activity +-16-32-15-18-19-28-35-703429-83-318-128
Cash from Financing Activity +6735-29-1-8390-6440-170-198-228-256
Net Cash Flow32-15-10144556-37-93350-137-5112
Free Cash Flow-35-351932125-37-5156-7861482373
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit-26%-19%70%96%133%6%15%75%39%49%120%94%

Financials of Medplus Health Services Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days110211111111
Inventory Days848276767810111311211711110699
Days Payable342925273137223027212422
Cash Conversion Cycle515351514865918291928379
Working Capital Days161214138254610058585449
ROCE %11%19%13%12%9%13%10%5%7%10%13%

Guidance history

How Medplus Health Services Ltd's guidance has moved, call by call

CallRevenueMarginsCapexFundraisingOrder book
Q1 FY27 call →20–40%FlatNone planned——
Q4 FY26 call →10–20%FlatPlanned——
Q3 FY26 call →10–20%FlatPlanned——
Q2 FY26 call →0–10%Flat———

What management guided on each call, newest first. Not investment advice, and not a forecast of returns.

11out of 100

Momentum score · price trend

11 out of 100 — Cooling

Over the past year its share price has done worse than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months−23.5%33%
Last 6 months−33.5%6%
Last 3 months−17.7%27%

The price is 52.7% below its all-time high of ₹1,225.65 (21 Jan 2022). Stocks more than 20% below their peak have their score halved, so 21 became 11.

How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Medplus Health Services Ltd: 0.4 × 33 + 0.4 × 6 + 0.2 × 27 = 21, halved to 11 because the price is more than 20% below its all-time high.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 30 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Continue your research

What Medplus Health Services Ltd's management said in earlier quarters

Others in Retailing this season

  • Aditya Birla Lifestyle Brands Ltd (Q2 FY27)

    2,266 Cr, up 11% YoY from Rs. Key investor presentation takeaways from Aditya Birla Lifestyle Brands Ltd's Q2 FY27 investor presentation — and how it ranks agai

  • Digidrive Dist. (Q2 FY27)

    1,024 lakhs in the same quarter of 2025, representing a year-on-year increase of approximately 34.4%. Key results statement takeaways from Digidrive Distributor

  • Crizac Ltd (Q2 FY27)

    Q2 FY27 Operating Income (Revenue):** ₹1,027 million . Key investor presentation takeaways from Crizac Ltd's Q2 FY27 investor presentation — and how it ranks ag

  • Aditya Vision (Q2 FY27)

    586 Cr, up 28.1% YoY from Rs. Key investor presentation takeaways from Aditya Vision Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers

Compare:vs Eternalvs Avenue Super.vs Trent Ltd